A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy.

@article{Tilley2012ARR,
  title={A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy.},
  author={Barbara C. Tilley and Arch G. Mainous and Jordan Jaskwhich Elm and E Elisabeth Pickelsimer and Lea H Soderstrom and Marvella E. Ford and Vanessa A. Diaz and Laura A. Siminoff and Keith E Burau and Daniel W. Smith},
  journal={Clinical trials},
  year={2012},
  volume={9 2},
  pages={188-97}
}
BACKGROUND Failure to include participants of diverse race and ethnicity (i.e. those other than European Caucasian, non-Hispanic) in clinical trials impedes the safe development of new therapies given the potential for racial/ethnicity-related variations in treatment response. Increasing diversity is problematic for low prevalence diseases, where most community-based approaches do not reach those with the disease. PURPOSE Increase racial/ethnic diversity of participants in a Parkinson's… CONTINUE READING